GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

A doctor and a patient discussing a therapy plan that includes pharmaceutical products. GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

North Carolina is listed as a location for the manufacture of AstraZeneca and Sanofi's respiratory syncytial virus (RSV) prevention antibody, nirsevimab, as well as for GSK's two-drug HIV regimen ...

April 15 (Reuters) - British pharmaceutical giant GSK (GSK.L), opens new tab has not met required ethical and regulatory standards in the marketing and prescription information for its Omjjara ...

The annual per capita pharmaceutical sales are less than US$32. Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are creating turbulence within the Pharma sector.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

GSK) stands against the other most undervalued biotech stocks to invest in. Trump’s Tariffs and the Pharma Sector On February 21, Jared Holz, Mizuho Securities America’s healthcare sector ...

GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to accelerate drug development and halt the nation’s slide down global life ...